Akanda (AKAN) Intangibles (2020 - 2025)
Akanda's (AKAN) quarterly Intangibles came in at $39.6 million in Q4 2025, up 249929.25% year-on-year from N/an in Q4 2024, and up 249929.25% quarter-over-quarter from $15827.0 in Q4 2024.
Akanda (AKAN) Intangibles (2020 - 2025) Analysis & Trends
Akanda's Intangibles history runs 6 years deep, the most recent figure standing at $39.6 million for Q4 2025.
- On a quarterly basis, Intangibles rose 249929.25% year-over-year to $39.6 million in Q4 2025; TTM through Dec 2025 was $39.6 million, a 249929.25% increase from a year earlier, with the FY2025 full-year figure at $39.6 million, up 249929.25% from the prior year.
- Intangibles rose to $39.6 million in Q4 2025 per AKAN's latest filing, from $15827.0 in the prior quarter.
- Across five years, Intangibles topped out at $39.6 million in Q4 2025 and bottomed at $2070.0 in Q4 2023.
- The 5-year median for Intangibles is $202710.5 (2021), against an average of $10.6 million.
- Across the five-year window, Intangibles sank 99.92% in 2024 and surged 249929.25% in 2025, its largest moves.
- Year by year, Intangibles stood at $389456.0 in 2021, then tumbled by 97.88% to $8254.0 in 2022, then sank by 74.92% to $2070.0 in 2023, then surged by 664.59% to $15827.0 in 2024, then jumped by 249929.25% to $39.6 million in 2025.
- Per Business Quant, the three latest AKAN Intangibles figures stand at $39.6 million (Q4 2025), $15827.0 (Q4 2024), and $15965.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 39.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39.57 Mn |
| Dec 31, 2024 | 15,827.00 |
| Jun 30, 2024 | 15,965.00 |
| Dec 31, 2023 | 2,070.00 |
| Jun 30, 2023 | 20.97 Mn |
| Dec 31, 2022 | 8,254.00 |
| Jun 30, 2022 | 23.45 Mn |
| Dec 31, 2021 | 389,456.00 |
| Dec 31, 2020 | 321,406.00 |